Carlsmed’s aprevo lumbar fusion implant could see increased CMS reimbursement under if its proposed 2027 rule goes into effect, according to a first-quarter earnings call.
Aprevo’s lumbar fusion already has strong hospital reimbursement, Carlsmed CEO Michael Cordonnier said in a May 5 earnings call. It’s covered by one of 11 different MS-DRG codes.
Under CMS’ proposed 20217 impatient prospective payment system, all aprevo lumbar spinal fusion procedures would be covered by one of three new MS-DRG codes—523, 524, or 525.
“If finalized as proposed, we see this development as very positive for patients, surgeons and hospitals to establish and maintain long-term access to the aprevo lumbar spine fusion procedure,” Mr. Cordonnier said, as transcribed by The Motley Fool.
Carlsmed saw a strong first quarter with $16.1 million in revenue, a 58% increase year over year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
